Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Press/Media
Student theses
Datasets
Search by expertise, name or affiliation
View Scopus Profile
Yi WANG, Prof
Assistant Professor
,
Department of Chemistry
https://orcid.org/0000-0003-4963-7371
Email
yiwang2
hkbu.edu
hk
2016
2025
Research activity per year
Overview
Fingerprint
Network
Projects / Grants
(6)
Research Output
(17)
Supervised Work
(1)
Fingerprint
Dive into the research topics where Yi WANG is active. Topic labels come from the works of this scholar. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Zein
87%
Biomimetic
78%
Nanoparticles
48%
Early Brain Development
39%
Triboelectric Nanogenerator
39%
Blood-brain Barrier
35%
Nanoencapsulation
31%
Neuronal Migration
29%
Therapeutic Efficiency
28%
Cancer Cells
28%
Early Postnatal Development
26%
Swainsonine
26%
Dentate Gyrus
26%
Prodrug Nanoparticles
26%
Triggered Drug Delivery
26%
Paclitaxel Prodrug
26%
Migrating Neurons
26%
Corticogenesis
26%
Multipolar-bipolar Transition
26%
Nanostructured Surfaces
26%
Drug Development
26%
Silk Fibroin
26%
Light-driven Hydrogen Production
26%
Cerebellar Glioblastoma
26%
Blood-brain Tumor Barrier
26%
Glioblastoma Therapy
26%
Infrared Therapy
26%
Cerebral Glioma
26%
Output Optimization
26%
Prodrug
26%
Iridium Complex
26%
Cyclometalated Iridium(III) Complex
26%
Visible Light
26%
Nanocarriers
26%
Conjugation
26%
Targeted Therapy
26%
Docosahexaenoic Acid
26%
Redox
26%
Stem Cells
26%
Cell-penetrating Peptide
26%
Anticancer Effect
26%
Doxorubicin
26%
Gelatin
26%
Near-infrared Imaging
26%
Human Mesenchymal Stem Cells (hMSCs)
26%
Maternal Exposure
26%
Milk
26%
Drug Carrier
26%
Nanoprobe
26%
Glioma
26%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Zein
71%
Docosahexaenoic Acid
47%
Malignant Neoplasm
41%
Prodrug
39%
Intracranial Tumor
39%
Blood-Brain Barrier
34%
Maize
28%
Solid Lipid Nanoparticle
26%
Nanocarrier
26%
Doxorubicin
26%
Drug Carrier
26%
Acid Protein
26%
Paclitaxel
26%
Drug Development
26%
Liver Disease
26%
Glioblastoma
26%
Shellac
26%
Reactive Oxygen Metabolite
26%
Brain Ischemia
21%
Folic Acid
18%
Dactolisib
18%
Diseases
17%
Nucleic Acid
15%
Reperfusion Injury
15%
Brain Injury
13%
Receptor
13%
Nanomaterial
13%
Degenerative Disease
13%
Contrast Medium
13%
Premature Labor
13%
Neoplasm
11%
Controlled Release
10%
Fatty Acid
10%
Clinical Trial
6%
Brain Disease
6%
Chemotherapy
6%
Cytotoxicity
6%
Anticarcinogen
5%
Liver Cell Carcinoma
5%
Drug
5%
Drug Antibody
5%
Drug
5%
Plant Protein
5%
Liver Cirrhosis
5%
Acute Hepatitis
5%
Combination Therapy
5%
Edible Plant
5%
Nanomedicine
5%
Microglia Polarization
5%
